| Ms Pamela Ann Wedum, MS, CCC-SLP | |
|
38 1st Ave Sw, Choteau, MT 59422-0110 | |
| (406) 466-2548 | |
| Not Available |
| Full Name | Ms Pamela Ann Wedum |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 38 1st Ave Sw, Choteau, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881902435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 143 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Pamela Ann Wedum, MS, CCC-SLP P.o. Box 1036, Choteau, MT 59422-1036 Ph: (406) 466-2548 | Ms Pamela Ann Wedum, MS, CCC-SLP 38 1st Ave Sw, Choteau, MT 59422-0110 Ph: (406) 466-2548 |
News Archive
Loyola University Health System is among the first centers to offer a new, nonsurgical treatment for Dupuytren's contracture, a debilitating condition that curls fingers toward the palm.
AbleNet, Inc. announces the agreement with Madentec Limited of Edmonton, Alberta, Canada for the exclusive global rights to manufacture and sell their entire line of assistive technology solutions. This adds a broad portfolio of proven devices to the AbleNet computer access products. Madentec will continue to own the products and provide engineering development support, which has been their core strength.
Frequently, depression and diabetes go hand in hand. And depression can be a major obstacle for people living with diabetes, making it less likely they'll stick to a medicine schedule or exercise regimen.
About 3.4 million people, or 13.9 percent of the population age 71 and older, have some form of dementia, the study found. As expected, the prevalence of dementia increased dramatically with age, from five percent of those aged 71 to 79 to 37.4 percent of those age 90 and older.
A gene known as TJP1 (tight junction protein 1) could help determine which multiple myeloma patients would best benefit from proteasome inhibitors such as bortezomib, as well as combination approaches to enhance proteasome inhibitor sensitivity, according to a study led by The University of Texas MD Anderson Cancer Center.
› Verified 4 days ago
Teton Medical Center Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 915 4th St Nw, Choteau, MT 59422 Phone: 406-466-5763 Fax: 406-466-5852 |